Not every member of the FDA advisory panel voted in favor of emergency situation use authorization for the Pfizer-BioNTech’s Covid vaccine. She signs up with “Squawk Box” by phone to go over to go over why she voted versus moving forward with Pfizer-BioNTech vaccine. Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC television for the current stock market news and analysis. From market futures to live price updates CNBC is the leader in service news worldwide.
The News with Shepard Smith is CNBC’s day-to-day news podcast offering deep, non-partisan protection and point of view on the day’s essential stories. Offered to listen by 8:30 pm ET/ 5:30 pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Not every member of the FDA advisory panel voted in favor of emergency usage authorization for the Pfizer-BioNTech’s Covid vaccine. Dr. Archana Chatterjee, Dean of the Chicago Medical School, was a member of the FDA committee. She joins “Squawk Box” by phone to go over to talk about why she voted versus moving forward with Pfizer-BioNTech vaccine. Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
